HLA studies in acquired immune deficiency syndrome patients with Kaposi's sarcoma
โ Scribed by Harry E. Prince; Robert W. Schroff; John L. Fahey
- Publisher
- Springer
- Year
- 1984
- Tongue
- English
- Weight
- 93 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0271-9142
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
I]. This is still a good description of the lesions seen in Kaposi's sarcoma. Usually the lesions are multicentric and may coalesce to form large plaques or tumors which can ulcerate. Spontaneous regression is occasionally seen. Invasion of deep soft tissues or bone and visceral involvement was seen
Pilot studies were conducted to evaluate the toxicity and efficacy of two relatively marrow-sparing chemotherapy regimens in the treatment of advanced or progressive epidemic Kaposi's sarcoma. Chemotherapy regimens consisted of bleomycin (10 mg/m2), vincristine (1.4 mg/m2, 2 mg maximum) and Adriamyc
## Abstract Kaposiโs sarcoma (KS) is the most frequent neoplasm in acquired immune deficiency syndrome (AIDS) patients. Whereas typical cases present as erythematous, plaque or nodular lesions, hyperkeratotic variants of AIDS-associated KS are rare. We describe five patients with AIDS-associated KS